Vanda Pharmaceuticals
Price & Volume
Stats
See more52W Range | $4.27-$9.94 |
Market Cap | $322.2M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $215.7M |
Revenue Growth (YoY) | -3.9% |
Gross Profit (12 Mos) | $202.2M |
Diluted EPS | -$4.68 |
News
See moreYahoo Finance • 3 months ago
Charcot-Marie-Tooth Disease Market Growth to Accelerate Significantly During the Forecast Period (2026-2036) Driven by the Launch of Emerging Disease-Modifying Therapies | DelveInsight
Yahoo Finance • 4 months ago
Is AnaptysBio (ANAB) One of the Best Performing Healthcare Stocks so Far in 2026?
Yahoo Finance • 4 months ago
Vanda targets $240M-$290M 2026 revenue as it introduces $10M-$30M NEREUS sales outlook
Yahoo Finance • 4 months ago
Model N Appoints Thomas Gibbs to Board of Directors
About
CEO | Dr. Mihael H. Polymeropoulos M.D. |
CFO | Mr. Kevin Patrick Moran |
Address | 2200 Pennsylvania Avenue NW, Washington, DC, United States, 20037 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 533 |